Cogent Biosciences, Inc. Forecasted to Post Q1 2024 Earnings of ($0.53) Per Share (NASDAQ:COGT)

Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities researchers at Wedbush dropped their Q1 2024 EPS estimates for shares of Cogent Biosciences in a note issued to investors on Monday, February 26th. Wedbush analyst D. Nierengarten now expects that the technology company will post earnings per share of ($0.53) for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post Brokers Set Expectations for Fate Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:FATE)
Next post Ambarella (NASDAQ:AMBA) PT Raised to $73.00